Il5 Products By Gene Name

405-ML) stimulates proliferation in the TF-1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Mouse IL-5 (0.5 ng/mL) is neutralized (green line) by increasing concentrations of Rat Anti-Human/Mouse IL-5 Monoclonal Antibody (Catalog # MAB405). The ND₅₀ is typically 0.004-0.015 µg/mL." class="big_lightbox"> 405-ML) stimulates proliferation in the TF-1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Mouse IL-5 (0.5 ng/mL) is neutralized (green line) by increasing concentrations of Rat Anti-Human/Mouse IL-5 Monoclonal Antibody (Catalog # MAB405). The ND₅₀ is typically 0.004-0.015 µg/mL." alt="Recombinant Mouse IL-5 (405-ML) stimulates proliferation in the TF-1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Mouse IL-5 (0.5 ng/mL) is neutralized (green line) by increasing concentrations of Rat Anti-Human/Mouse IL-5 Monoclonal Antibody (Catalog # MAB405). The ND₅₀ is typically 0.004-0.015 µg/mL." class="big_thumb" />

Fluorescent ICC Staining of Non-adherent Cells." class="big_lightbox"> Fluorescent ICC Staining of Non-adherent Cells." alt="IL‑5 was detected in immersion fixed human peripheral blood lymphocytes using Mouse Anti-Human IL‑5 Monoclonal Antibody (Catalog # MAB605) at 5 µg/mL for 3 hours at room temperature. Cells were stained (red) and counterstained (green). Specific labeling was localized to the cytoplasm of PBMCs. View our protocol for Fluorescent ICC Staining of Non-adherent Cells." class="big_thumb" />

MAB002, open histogram), followed by Fluorescein-conjugated Anti-Mouse IgG F(ab')₂Secondary Antibody (Catalog # F0103B). To facilitate intracellular staining, cells were fixed with paraformaldehyde and permeabilized with saponin." class="big_lightbox"> MAB002, open histogram), followed by Fluorescein-conjugated Anti-Mouse IgG F(ab')₂Secondary Antibody (Catalog # F0103B). To facilitate intracellular staining, cells were fixed with paraformaldehyde and permeabilized with saponin." class="big_thumb" />

3137-PL) stimulates proliferation in the TF-1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Porcine IL-5 (25 ng/mL) is neutralized (green line) by increasing concen-trations of Goat Anti-Porcine IL-5 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3137). The ND₅₀ is typically <5 µg/mL." class="big_lightbox"> 3137-PL) stimulates proliferation in the TF-1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Porcine IL-5 (25 ng/mL) is neutralized (green line) by increasing concen-trations of Goat Anti-Porcine IL-5 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3137). The ND₅₀ is typically <5 µg/mL." alt="Recombinant Porcine IL-5 (Catalog # 3137-PL) stimulates proliferation in the TF-1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Porcine IL-5 (25 ng/mL) is neutralized (green line) by increasing concen-trations of Goat Anti-Porcine IL-5 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3137). The ND₅₀ is typically <5 µg/mL." class="big_thumb" />

NL001) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Non-adherent Cells." class="big_lightbox"> NL001) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Non-adherent Cells." class="big_thumb" />

205-IL) stimulates proliferation in the TF‑1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human IL‑5 (1.25 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human IL‑5 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-205-NA). The ND₅₀ is typically 0.3-0.9 µg/mL." class="big_lightbox"> 205-IL) stimulates proliferation in the TF‑1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human IL‑5 (1.25 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human IL‑5 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-205-NA). The ND₅₀ is typically 0.3-0.9 µg/mL." alt="Recombinant Human IL‑5 (Catalog # 205-IL) stimulates proliferation in the TF‑1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human IL‑5 (1.25 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human IL‑5 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-205-NA). The ND₅₀ is typically 0.3-0.9 µg/mL." class="big_thumb" />

2470-EL) stimulates proliferation in the TF-1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Equine IL-5 (50 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Equine IL-5 Antigen Affinity-purified Poly-clonal Antibody (Catalog # AF2470). The ND₅₀ is typically 0.500-6.00 µg/mL." class="big_lightbox"> 2470-EL) stimulates proliferation in the TF-1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Equine IL-5 (50 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Equine IL-5 Antigen Affinity-purified Poly-clonal Antibody (Catalog # AF2470). The ND₅₀ is typically 0.500-6.00 µg/mL." alt="Recombinant Equine IL-5 (2470-EL) stimulates proliferation in the TF-1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Equine IL-5 (50 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Equine IL-5 Antigen Affinity-purified Poly-clonal Antibody (Catalog # AF2470). The ND₅₀ is typically 0.500-6.00 µg/mL." class="big_thumb" />

NL001) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Non-adherent Cells." class="big_lightbox"> NL001) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Non-adherent Cells." class="big_thumb" />